Randomized trial comparing three different regimens of alpha-2a-interferon in chronic hepatitis C

Hepatology

Volumn 22, Issue 3, 1995, Pages 700-706

  Chemello, Liliana ^a   Bonetti, Paola ^a   Cavalletto, Luisa ^a   Talato, Fabiola ^a   Donadon, Valter ^b   Casarin, Pietro ^c   Belussi, Fabio ^d   Frezza, Mario ^e   Noventa, Franco ^a   Pontisso, Patrizia ^a   Benvegnu, Luisa ^a   Casarin, Carla ^a   Alberti, Alfredo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b III Medical Division   (Italy)

^c Sacile Hospital   (Italy)

^d Venice Hospital   (Italy)

^e UNIVERSITY OF TRIESTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA2A INTERFERON; ANTIVIRUS AGENT;

ADULT; AGED; ARTICLE; CHRONIC HEPATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DOSE RESPONSE; DRUG EFFICACY; FEMALE; GENOTYPE; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; AGED; CHRONIC DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERFERON ALFA-2A; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 0029156655     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1016/0270-9139(95)90286-4     Document Type: Article

References (16)

1. The NANB post-transfusion hepatitis
2. Recombinant interferon alpha therapy for chronic hepatitis
3. Treatment of chronic hepatitis C with recombinant interferon alpha
4. Recombinant human alpha-interferon in patients with chronic Non-A, Non-B hepatitis: a multicenter randomized controlled trial from France
5. High doses of recombinant alpha-interferon or gamma-interferon for chronic hepatitis C: a randomized, controlled trial
6. Treatment with interferon(s) of community-acquired chronic hepatitis and cirrhosis type C
7. Treatment of chronic hepatitis C with high dose alpha-interferon-2b: a multicenter study
8. Genotypes of hepatitis C virus in Italian patients with chronic hepatitis C
9. Mapping of serotype-specific immunodominant epitopes in the NS4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infection with HCV types-1,2 and 3
10. Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C
11. Discrepancy between biochemical and virological responses to interferon-alpha in chronic hepatitis C
12. Predictors of response to alpha-interferon (IFN) in chronic hepatitis C: a multivariate analysis on 361 treated patients
13. Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alfa therapy: relationship to genotypes of hepatitis C virus
14. Hepatitis C serotype and response to interferon therapy
15. Quantitative analysis of hepatitis C virus RNA in serum during interferon-alfa therapy
16. Hepatitis C viraemia in chronic liver disease: relationship to interferon-alfa or corticosteroid treatment